Atovaquone

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2764 publications

Redox and structural determinants of mitochondrial complex III inhibition by triphenylphosphonium-conjugated atovaquone analogs.

Redox and structural determinants of mitochondrial complex III inhibition by triphenylphosphonium-conjugated atovaquone analogs.

Journal: Redox biology

Published: July 30, 2026

Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.

Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.

Journal: BMC cancer

Published: July 20, 2026

Mutations in apicoplast rRNA genes are associated with clindamycin resistance and impair the ability of malaria parasites to infect mosquitoes.

Mutations in apicoplast rRNA genes are associated with clindamycin resistance and impair the ability of malaria parasites to infect mosquitoes.

Journal: Antimicrobial agents and chemotherapy

Published: July 15, 2026

Dihydroorotate Dehydrogenase Inhibitors are Potent Antiviral Agents against Henipaviruses and Arenaviruses.

Dihydroorotate Dehydrogenase Inhibitors are Potent Antiviral Agents against Henipaviruses and Arenaviruses.

Journal: Antiviral research

Published: July 08, 2026

Cascade-Enhanced Chemodynamic Therapy via a Mitochondria-Targeted PEI-Fc-Gox Nanogel with Dual Antihypoxia and ROS Amplification.

Cascade-Enhanced Chemodynamic Therapy via a Mitochondria-Targeted PEI-Fc-Gox Nanogel with Dual Antihypoxia and ROS Amplification.

Journal: Biomacromolecules

Published: July 08, 2026

Low-dose atovaquone for prophylaxis of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: an open-label, multicentre, single-arm, phase II trial.

Low-dose atovaquone for prophylaxis of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: an open-label, multicentre, single-arm, phase II trial.

Journal: EULAR rheumatology open

Published: June 29, 2026

Duplication of superoxide dismutase and a mutation in aquaglyceroporin mediates the sensitivity of Plasmodium falciparum to cryptosporin, a natural product derived from Acaromyces ingoldii.

Duplication of superoxide dismutase and a mutation in aquaglyceroporin mediates the sensitivity of Plasmodium falciparum to cryptosporin, a natural product derived from Acaromyces ingoldii.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Single-cell analysis of Plasmodium falciparum transcripts after drug perturbation identifies feedback regulation as well as increased transmission potential.

Single-cell analysis of Plasmodium falciparum transcripts after drug perturbation identifies feedback regulation as well as increased transmission potential.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential.

Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential.

Journal: Genes

Published: June 02, 2026

Identifying candidate therapeutic targets in amyotrophic lateral sclerosis through a transcriptome-wide machine-learning consensus approach for drug repurposing.

Identifying candidate therapeutic targets in amyotrophic lateral sclerosis through a transcriptome-wide machine-learning consensus approach for drug repurposing.

Journal: Neuroscience

Published: May 27, 2026

Legacy 4(1H)-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection.

Legacy 4(1H)-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection.

Journal: ACS infectious diseases

Published: May 26, 2026

Targeting Membrane Transport and Energy Metabolism for the Identification of Repurposed Drug Candidates Against Neisseria gonorrhoeae Using an In Silico Strategy.

Targeting Membrane Transport and Energy Metabolism for the Identification of Repurposed Drug Candidates Against Neisseria gonorrhoeae Using an In Silico Strategy.

Journal: Antibiotics (Basel, Switzerland)

Published: May 18, 2026

Showing 1-12 of 2,764

Last Updated: 09/26/2026